Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis
about
Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOGA promising therapeutic approach for treatment of posterior uveitis: recombinant T cell receptor ligand protects Lewis rats from acute and recurrent experimental autoimmune uveitis.Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppressionDifferent immunological mechanisms govern protection from experimental stroke in young and older mice with recombinant TCR ligand therapy.Gene expression in the spinal cord in female lewis rats with experimental autoimmune encephalomyelitis induced with myelin basic proteinRTL therapy for multiple sclerosis: a Phase I clinical study.Gilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitisSystemic immunomodulation of autoimmune disease using MHC-derived recombinant TCR ligandsMHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritis.Partial MHC Constructs Treat Thromboembolic Ischemic Stroke Characterized by Early Immune ExpansionRecombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosisClass II major histocompatibility complex tetramer staining: progress, problems, and prospects.Recombinant T cell receptor ligand treats experimental stroke.Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligandSex differences in the immune response to experimental stroke: Implications for translational research.A novel HLA-DRα1-MOG-35-55 construct treats experimental strokeSingle-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury.Gene Network Analysis of Interstitial Macrophages After Treatment with Induced Pluripotent Stem Cells Secretome (iPSC-cm) in the Bleomycin Injured Rat Lung.
P2860
Q33838187-8E4381FD-44DA-4CB4-A08E-A94D94A76FAFQ33928060-C784FA53-C709-40AC-9EC5-E47B8437CEDDQ34077153-3EBBF8CE-F226-4C05-B46F-CFC715A38D93Q34175958-71E760DB-16C5-41A2-AA4A-A0ABCCF0C11AQ34242088-C0AAD8B3-85A0-4830-9BAE-277EEE484EB6Q34472020-605B9444-CDEC-4B2B-B3BC-D6B35C267C02Q34520672-93F7F56C-E046-4A33-8537-A89BEA4BC6FBQ35946934-77392471-9247-4009-8DAC-FFAA49BA9FD1Q36107636-63196684-B4C9-407D-99F7-19C634B5311CQ36278295-2150FE35-F54D-4E06-A611-9018F1B6144AQ36790648-C94AC8D6-F6E7-4D69-909E-939456BEB08FQ37068900-F55E5BA6-B4F3-4FEE-8843-249AC4E92ECBQ37077802-BDE204D7-EA47-4A91-862A-5BACEF71B6EAQ37246578-58E8E5E9-6EF3-4AAA-B3CE-8075B5E266D2Q37250118-9A1C6BD3-FF1B-4FE0-A46C-D526D01E9930Q37432327-E69E5F20-24BC-48A8-8908-37B23C8F65F8Q37684577-6A9E4575-E24D-43BC-BDC5-AAEB553B0FECQ41549575-DA171C17-8FF0-446B-B85E-20F3832B70C1Q48011437-9B3C47C0-8AE8-4D46-BB75-42F06F422DFEQ52408795-3173934B-929A-4C97-9953-AA4BA1954999
P2860
Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis
description
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1998
@ast
im Dezember 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1998/12/01)
@sk
vědecký článek publikovaný v roce 1998
@cs
wetenschappelijk artikel (gepubliceerd op 1998/12/01)
@nl
наукова стаття, опублікована в грудні 1998
@uk
مقالة علمية (نشرت في ديسمبر 1998)
@ar
name
Two-domain MHC class II molecu ...... l autoimmune encephalomyelitis
@ast
Two-domain MHC class II molecu ...... l autoimmune encephalomyelitis
@en
Two-domain MHC class II molecu ...... l autoimmune encephalomyelitis
@nl
type
label
Two-domain MHC class II molecu ...... l autoimmune encephalomyelitis
@ast
Two-domain MHC class II molecu ...... l autoimmune encephalomyelitis
@en
Two-domain MHC class II molecu ...... l autoimmune encephalomyelitis
@nl
prefLabel
Two-domain MHC class II molecu ...... l autoimmune encephalomyelitis
@ast
Two-domain MHC class II molecu ...... l autoimmune encephalomyelitis
@en
Two-domain MHC class II molecu ...... l autoimmune encephalomyelitis
@nl
P2093
P1476
Two-domain MHC class II molecu ...... l autoimmune encephalomyelitis
@en
P2093
A. A. Vandenbark
B. F. Bebo
G. G. Burrows
K. L. Adlard
P304
P407
P577
1998-12-01T00:00:00Z